中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
2期
15-16
,共2页
董保国%谢桂生%李霖%韦皓棠
董保國%謝桂生%李霖%韋皓棠
동보국%사계생%리림%위호당
雷替曲塞%奥沙利铂%晚期大肠癌%氟尿嘧啶%化学治疗
雷替麯塞%奧沙利鉑%晚期大腸癌%氟尿嘧啶%化學治療
뢰체곡새%오사리박%만기대장암%불뇨밀정%화학치료
Raltitrexed%Oxaliplatin%Advanced colorectal cancer%Fluorouraci%Chemotherapy
目的:探讨雷替曲塞联合奥沙利铂治疗术后复发晚期大肠癌的临床疗效。方法:选取2010年4月-2013年4月入住本院普外科接受治疗的76例术后复发晚期大肠癌患者,按照随机数字表法将其分为治疗组和对照组各38例,其中治疗组给予雷替曲塞联合奥沙利铂化疗;对照组给予氟尿嘧啶联合奥沙利铂化疗。观察比较两组患者在治疗效果、不良反应等方面的差异。结果:治疗组总有效率44.74%,明显高于对照组的13.16%,比较差异有统计学意义(X2=8.02,P<0.05)。治疗组发生呕吐14例,不良反应发生率为36.84%,对照组发生呕吐25例,不良反应发生率为65.79%,治疗组的不良反应发生率明显低于对照组,比较差异有统计学意义(X2=6.37,P<0.05)。结论:雷替曲塞联合奥沙利铂治疗术后复发晚期大肠癌效果显著,不良反应少,值得广泛应用于临床。
目的:探討雷替麯塞聯閤奧沙利鉑治療術後複髮晚期大腸癌的臨床療效。方法:選取2010年4月-2013年4月入住本院普外科接受治療的76例術後複髮晚期大腸癌患者,按照隨機數字錶法將其分為治療組和對照組各38例,其中治療組給予雷替麯塞聯閤奧沙利鉑化療;對照組給予氟尿嘧啶聯閤奧沙利鉑化療。觀察比較兩組患者在治療效果、不良反應等方麵的差異。結果:治療組總有效率44.74%,明顯高于對照組的13.16%,比較差異有統計學意義(X2=8.02,P<0.05)。治療組髮生嘔吐14例,不良反應髮生率為36.84%,對照組髮生嘔吐25例,不良反應髮生率為65.79%,治療組的不良反應髮生率明顯低于對照組,比較差異有統計學意義(X2=6.37,P<0.05)。結論:雷替麯塞聯閤奧沙利鉑治療術後複髮晚期大腸癌效果顯著,不良反應少,值得廣汎應用于臨床。
목적:탐토뢰체곡새연합오사리박치료술후복발만기대장암적림상료효。방법:선취2010년4월-2013년4월입주본원보외과접수치료적76례술후복발만기대장암환자,안조수궤수자표법장기분위치료조화대조조각38례,기중치료조급여뢰체곡새연합오사리박화료;대조조급여불뇨밀정연합오사리박화료。관찰비교량조환자재치료효과、불량반응등방면적차이。결과:치료조총유효솔44.74%,명현고우대조조적13.16%,비교차이유통계학의의(X2=8.02,P<0.05)。치료조발생구토14례,불량반응발생솔위36.84%,대조조발생구토25례,불량반응발생솔위65.79%,치료조적불량반응발생솔명현저우대조조,비교차이유통계학의의(X2=6.37,P<0.05)。결론:뢰체곡새연합오사리박치료술후복발만기대장암효과현저,불량반응소,치득엄범응용우림상。
Objective:To investigate the clinical efficacy of raltitrexed combined with oxaliplatin in the treatment of postoperative recurrence of advanced colorectal cancer.Method:Seventy-six patients with postoperative recurrence of advanced colorectal cancer were selected in our hospital from April 2010 to April 2013,they were randomly divided into the treatment group and the control group,38 cases in each group.The treatment group was given raltitrexed combined with oxaliplatin chemotherapy,the control group was given fluorouracil combined with oxaliplatin chemotherapy,the differences in the therapeutic effect and adverse reaction of two groups were compared.Result:The total efficiency of treatment group was 44.74%,it was significantly higher than 13.16%of the control group,the difference was statistically significant( X2=8.02,P<0.05),vomiting of the treatment group was 14 cases,adverse reaction rate was 36.84%,vomiting of the control group was 25 cases,adverse reaction rate was 65.79%,the difference was statistically significant(X2=6.37,P<0.05).Conclusion:The effect of raltitrexed combined with oxaliplatin in the treatment of postoperative recurrence of advanced colorectal cancer is effective,safe and feasible,it’s worthy in the clinical application.